No,구분,개별,평가의뢰일,평가의뢰기관,재평가,평가의뢰종목,법인번호,평가종류,회차,민감도,주기,기준일,평가값송부일,보고서송부일,민감도송부일,평가담당자,공수,전기평가,RM,결과보고서송부,등록월,등록그룹,담당자,연락처,Mail,평가목적,종목등록일
1036,-,개별종목,2024-05-27,유진투자증권,재평가,아시아나항공,1101110562804 ,D02,2,-,반기 ,2024-06-30,평가철회,평가철회,-,상장, - ,상장,이현승,이현승,평가철회,평가철회,"정진영사원, 채용석부장","02-368-6234, 02-368-6224",jin0@eugenefn.com;  yschae@eugenfn.com,-,0
3429,"2차평가값 : 2024-06-21, 최종평가값 : 2024-06-28(상장종가반영)",개별종목,2024-05-31,KB인베스트먼트,재평가,"업라이즈(구,헤이비트)",1101116635530 ,A07,2,-,분기 ,2024-06-30,평가철회,평가철회,평가철회,서경덕, 1.0 ,변혜진,최수민,최수민,평가철회,평가철회,경영기획그룹곽예은계장 ,02-3015-4782 ,ye.kwak@kbfg.com ,-,0
3430,"2차평가값 : 2024-06-21, 최종평가값 : 2024-06-28(상장종가반영)",개별종목,2024-05-31,KB인베스트먼트,재평가,"업라이즈(구,헤이비트)",1101116635530 ,A07,3,-,분기 ,2024-06-30,평가철회,평가철회,평가철회,서경덕, - ,변혜진,최수민,최수민,평가철회,평가철회,경영기획그룹곽예은계장 ,02-3015-4782 ,ye.kwak@kbfg.com ,-,0
3431,"2차평가값 : 2024-06-21, 최종평가값 : 2024-06-28(상장종가반영)",개별종목,2024-05-31,KB인베스트먼트,재평가,"업라이즈(구,헤이비트)",1101116635530 ,A07,4,-,분기 ,2024-06-30,평가철회,평가철회,평가철회,서경덕, - ,변혜진,최수민,최수민,평가철회,평가철회,경영기획그룹곽예은계장 ,02-3015-4782 ,ye.kwak@kbfg.com ,-,0
3456,"2차평가값 : 2024-06-21, 최종평가값 : 2024-06-28(상장종가반영)",개별종목,2024-05-31,KB인베스트먼트,재평가,패스트파이브,1101115648899 ,A07,0,-,분기 ,2024-06-30,평가철회,평가철회,평가철회,정재형, 1.0 ,정재형,최수민,최수민,평가철회,평가철회,경영기획그룹곽예은계장 ,02-3015-4782 ,ye.kwak@kbfg.com ,-,0
3540,"2차평가값 : 2024-06-21, 최종평가값 : 2024-06-28(상장종가반영)",개별종목,2024-05-31,KB인베스트먼트,신규,Mighty Buildings,KBP2024060016,A01,0,-,분기 ,2024-06-30,2024-06-18,2024-07-11,2024-07-17,원정우, 1.0 ,신규,최수민,최수민,202406,[Y]금융기관,경영기획그룹곽예은계장 ,02-3015-4782 ,ye.kwak@kbfg.com ,-,0
5865,-,개별종목,2024-06-07,나우아이비캐피탈,재평가,우양에이치씨,1350110062633 ,A01,0,-,반기 ,2024-06-30,평가철회,평가철회,-,윤광일, 1.0 ,고명주,유재호,유재호,평가철회,평가철회,민경웅수석,"02-565-6234,010-6684-6454",mkw@nauib.com,-,0
6627,-,기초자산,현대해상펀드(기초자산),아주좋은벤처펀드2.0,신규,"Cohere, Inc.",KBP2024060048,A05,0,-,연말,2024-06-30,2024-07-02,보고서제공X,-,오영석, - ,신규,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6628,-,개별종목,2024-07-02,핑거스토리,재평가,핑거스토리,1101116679992 ,D02,3,-,분기 ,2024-06-25,2024-07-10,2024-07-17,-,상장, - ,상장,-,-,202406,[X]일반기업,권택영부장,010-4176-0493,kwonty86@gtf-group.co.kr,회계반영,0
6629,-,기초자산,현대차증권펀드(기초자산),아이엠엠인프라제9호의베타사모투자,신규,엔에치엔클라우드,1311110666966 ,A05,0,-,분기,2024-06-30,2024-07-05,보고서제공X,-,원정우, - ,신규,-,-,202406,[6]기타기관펀드(기초자산),0,0,0,-,0
6630,-,개별종목,2024-07-02,알체라,재평가,알체라,1101116080032 ,D02,22,-,분기 ,2024-06-28,2024-07-09,2024-07-16,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,이슬기매니저,010-3134-7877,sg.lee@alcherainc.com,회계반영,0
6631,-,개별종목,2024-07-02,나무기술,재평가,나무기술,1101116016673 ,D03,7,-,분기 ,2024-06-30,2024-07-19,2024-07-26,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,안진선팀장 ,010-6532-9965 ,jinsun.an@namutech.co.kr ,회계반영,0
6632,-,개별종목,2024-07-02,나무기술,재평가,나무기술,1101116016673 ,D01,8,-,분기 ,2024-06-30,2024-07-19,2024-07-26,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,안진선팀장 ,010-6532-9965 ,jinsun.an@namutech.co.kr ,회계반영,0
6633,-,개별종목,2024-07-02,레뷰코퍼레이션,신규,레뷰코퍼레이션,1101115576438 ,D06,0,-,미정,2024-07-08,2024-07-09,2024-07-16,-,상장, - ,상장,-,메자닌평가팀,202407,[W]상장기업,백영진,"02-6959-9851, 010-5757-5893",yjbaek0419@revu.net,회계반영,0
6634,-,개별종목,2024-07-02,교보증권(투자금융1부),재평가,센트럴세종,1501110285523 ,D02,1,-,분기,2024-06-30,2024-07-03,2024-07-10,-,서경덕, 1.0 ,서경덕,서경덕,서경덕,202406,[Y]금융기관,윤병희대리,02-3771-9129,pfbyung@naver.com,회계반영,0
6635,-,개별종목,2024-07-02,교보증권(투자금융1부),재평가,센트럴세종,1501110285523 ,D02,2,-,분기,2024-06-30,2024-07-03,2024-07-10,-,서경덕, - ,서경덕,서경덕,서경덕,202406,[Y]금융기관,윤병희대리,02-3771-9129,pfbyung@naver.com,회계반영,0
6636,-,개별종목,2024-07-02,신테카바이오,재평가,신테카바이오,1101114179457 ,D02,1,-,반기 ,2024-06-30,2024-07-09,2024-07-16,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202407,[W]상장기업,양아영과장,"070-7683-1408, 010-4760-3756 ",yay@syntekabio.com ,회계반영,0
6637,-,개별종목,2024-07-02,신테카바이오,재평가,신테카바이오,1101114179457 ,D02,2,-,반기 ,2024-06-30,2024-07-09,2024-07-16,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202407,[W]상장기업,양아영과장,"070-7683-1408, 010-4760-3756 ",yay@syntekabio.com ,회계반영,0
6638,-,개별종목,2024-07-02,신테카바이오,재평가,신테카바이오,1101114179457 ,D02,3,-,반기 ,2024-06-30,2024-07-09,2024-07-16,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202407,[W]상장기업,양아영과장,"070-7683-1408, 010-4760-3756 ",yay@syntekabio.com ,회계반영,0
6639,-,개별종목,2024-07-02,신테카바이오,재평가,신테카바이오,1101114179457 ,D02,22,-,반기 ,2024-06-30,2024-07-09,2024-07-16,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202407,[W]상장기업,양아영과장,"070-7683-1408, 010-4760-3756 ",yay@syntekabio.com ,회계반영,0
6640,-,개별종목,2024-07-02,신테카바이오,재평가,신테카바이오,1101114179457 ,D02,33,-,반기 ,2024-06-30,2024-07-09,2024-07-16,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202407,[W]상장기업,양아영과장,"070-7683-1408, 010-4760-3756 ",yay@syntekabio.com ,회계반영,0
6641,-,개별종목,2024-07-01,IBK투자증권(투자금융팀),신규,레이크브릿지제8호사모투자,KBP2024060049,B01,0,-,분기,2024-06-30,2024-07-04,2024-07-09,-,서경덕, 1.0 ,신규,서경덕,서경덕,202406,[Y]금융기관,박태우선임,02-6915-5390,sliding_had@ibks.com,회계반영,0
6642,-,개별종목,2024-07-02,리딩에이스캐피탈,재평가,템퍼스인베스트먼트,1101114782200 ,A07,1,-,반기,2024-06-30,2024-07-12,2024-07-22,-,김예림, - ,김예림,김예림,김예림,202406,[Y]금융기관,최정애차장,02-6268-6764,jachoi@leading.co.kr,-,0
6643,-,개별종목,2024-07-02,큐캐피탈파트너스,재평가,큐로컴,1101111407314 ,D02,21,-,연말,2024-06-30,2024-07-08,2024-07-11,-,상장, - ,상장,-,-,202404,[Y]금융기관,진윤정팀장,02-559-6236,rose@qcapital.co.kr,회계반영,0
6644,-,개별종목,2024-07-02,큐캐피탈파트너스,재평가,큐로컴,1101111407314 ,D02,22,-,연말,2024-06-30,2024-07-08,2024-07-11,-,상장, - ,상장,-,-,202404,[Y]금융기관,진윤정팀장,02-559-6236,rose@qcapital.co.kr,회계반영,0
